The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERON PHARMA INC | COM | 00434H108 | 352,586 | 2,600,000 | SH | OTR | 2,600,000 | 0 | 0 | ||
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 16,550 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,520 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 14,790 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 3,955 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
AGILE GROWTH CORP | UNIT 03/09/2026 | G01202129 | 11,904 | 1,200,000 | SH | OTR | 1,200,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 64,550 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 8,813 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 153,360 | 676,400 | SH | OTR | 676,400 | 0 | 0 | ||
ALKURI GLOBAL ACQUISITION CO | UNIT 01/01/2028 | 66981N202 | 3,952 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 98,833 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
ALPHA CAPITAL ACQUISITION CO | UNIT 02/16/2026 | G0316P114 | 792 | 79,598 | SH | OTR | 79,598 | 0 | 0 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 836,453 | 404,351 | SH | OTR | 404,351 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 988 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
AMYRIS INC | COM NEW | 03236M200 | 257,850 | 13,500,000 | SH | OTR | 13,500,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 40,531 | 1,455,846 | SH | OTR | 1,455,846 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 296,134 | 825,000 | SH | OTR | 825,000 | 0 | 0 | ||
AON PLC | SHS CL A | G0403H108 | 564,735 | 2,454,194 | SH | OTR | 564,735 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 93,329 | 2,175,000 | SH | OTR | 2,175,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | NOTE 3.500% 9/1 | 03753UAB2 | 4,886 | 3,522,000 | PRN | OTR | 3,522,000 | 0 | 0 | ||
APHRIA INC | COM | 03765K104 | 50,808 | 2,765,800 | SH | OTR | 2,765,800 | 0 | 0 | ||
APOLLO STRATEGIC GRWT CPTL I | UNIT 99/99/9999 | G0412A110 | 7,485 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
ARAMARK | COM | 03852U106 | 410,610 | 10,868,450 | SH | OTR | 10,868,450 | 0 | 0 | ||
ARCLIGHT CLEAN TRANSITION II | UNIT 03/16/2028 | G0R21B120 | 7,500 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
ARCTOS NORTHSTAR ACQUIS CORP | UNIT 99/99/9999 | G0477L118 | 1,998 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 58,982 | 850,000 | SH | OTR | 850,000 | 0 | 0 | ||
ARES ACQUISITION CORPORATION | UNIT 99/99/9999 | G33032114 | 10,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 11,435 | 172,454 | SH | OTR | 172,454 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 8,320 | 800,000 | SH | OTR | 800,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 128,880 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ATENTO S A | SHS | L0427L204 | 46,815 | 2,230,357 | SH | OTR | 2,230,357 | 0 | 0 | ||
AUSTERLITZ ACQUISITION CORP | UNIT 99/99/9999 | G0633D117 | 5,020 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
AUSTERLITZ ACQUISITION CORP | UNIT 99/99/9999 | G0633U119 | 15,045 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
AVITA MEDICAL INC | COM | 05380C102 | 15,856 | 800,000 | SH | OTR | 800,000 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 9,391 | 740,000 | SH | OTR | 740,000 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 47,422 | 592,481 | SH | OTR | 592,481 | 0 | 0 | ||
BHP GROUP PLC | SPONSORED ADR | 05545E209 | 231,470 | 4,000,521 | SH | OTR | 1 | 4,000,521 | 0 | 0 | |
BIOATLA INC | COM | 09077B104 | 75,856 | 1,492,060 | SH | OTR | 1,492,060 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 28,814 | 103,000 | SH | OTR | 103,000 | 0 | 0 | ||
BLACKSTONE GROUP INC | COM | 09260D107 | 330,251 | 4,431,121 | SH | OTR | 4,431,121 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 67,555 | 694,791 | SH | OTR | 694,791 | 0 | 0 | ||
BOLT BIOTRAPEUTICS INC | COM | 097702104 | 8,228 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 495,604 | 12,822,869 | SH | OTR | 12,822,869 | 0 | 0 | ||
BROADCOM INC | COM | 11135F101 | 316,331 | 682,247 | SH | OTR | 682,247 | 0 | 0 | ||
BROADMARK RLTY CAP INC | COM | 11135B100 | 75,000 | 7,170,213 | SH | OTR | 7,170,213 | 0 | 0 | ||
BROADMARK RLTY CAP INC | *W EXP 11/15/202 | 11135B118 | 1,636 | 7,174,613 | SH | OTR | 7,174,613 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 53,515 | 2,465,000 | SH | OTR | 2,465,000 | 0 | 0 | ||
CASCADE ACQUISITION CORP | COM CL A | 147151104 | 9,702 | 990,000 | SH | OTR | 990,000 | 0 | 0 | ||
CASCADE ACQUISITION CORP | *W EXP 11/30/202 | 147151112 | 446 | 495,000 | SH | OTR | 495,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 359,494 | 5,625,000 | SH | OTR | 5,625,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/202 | 15678U102 | 566 | 134,175 | SH | OTR | 134,175 | 0 | 0 | ||
CF ACQUISITION CORP VI | UNIT 99/99/9999 | 12521J202 | 990 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 280,237 | 454,178 | SH | OTR | 454,178 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 12,532 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
CHURCHILL CAPITAL CORP VI | UNIT 99/99/9999 | 17143W200 | 4,024 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
CHURCHILL CAPITAL CORP VII | UNIT 99/99/9999 | 17144M201 | 9,970 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
CLEVER LEAVES HOLDINGS INC | COM | 186760104 | 23,441 | 2,278,079 | SH | OTR | 2,278,079 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | NOTE 1.250% 5/0 | 189464AC4 | 39,243 | 51,910,000 | PRN | OTR | 51,910,000 | 0 | 0 | ||
CM LIFE SCIENCES II INC | UNIT 02/25/2028 | 125842203 | 3,200 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
COLONNADE ACQUISITION CORP I | UNIT 99/99/9999 | G2284B127 | 4,925 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 7,400 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 23,390 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
CORAZON CAPITAL V838 MONOCER | UNIT 03/24/2026 | G24237110 | 9,950 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
CORELOGIC INC | COM | 21871D103 | 77,269 | 975,000 | SH | OTR | 975,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 5,209 | 125,000 | SH | OTR | 125,000 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 11,320 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 58,150 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
DARIOHEALTH CORP | COM NEW | 23725P209 | 11,556 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
DECARBONIZATION PLUS ACQU II | UNIT 03/19/2026 | 24279D204 | 19,920 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 13,452 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
DERMTECH INC | COM | 24984K105 | 10,158 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
DISRUPTIVE ACQUISITION CORP | UNIT 03/06/2026 | G2770Y110 | 13,832 | 1,400,000 | SH | OTR | 1,400,000 | 0 | 0 | ||
DRAGONEER GROWTH OPT CORP II | CL A SHS | G28315102 | 2,528 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 98,393 | 1,995,000 | SH | OTR | 1,995,000 | 0 | 0 | ||
EQUIFAX INC | COM | 294429105 | 109,879 | 606,629 | SH | OTR | 606,629 | 0 | 0 | ||
EQUILLIUM INC | COM | 29446K106 | 4,862 | 680,000 | SH | OTR | 680,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 242,843 | 10,750,000 | SH | OTR | 10,750,000 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 412,108 | 1,399,205 | SH | OTR | 1,399,205 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 156,655 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 58,441 | 1,683,700 | SH | OTR | 1,683,700 | 0 | 0 | ||
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 441,841 | 3,142,318 | SH | OTR | 3,142,318 | 0 | 0 | ||
FIFTH WALL ACQUISITION CORP | COM CL A | 316790104 | 5,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
FINCH THERAPEUTICS GROUP INC | COM | 31773D101 | 6,205 | 390,000 | SH | OTR | 390,000 | 0 | 0 | ||
FINSERV ACQUISITION CORP II | UNIT 02/17/2026 | 31809Y202 | 5,979 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
FIRST RESERVE SUSTAINABLE GW | UNIT 03/05/2026 | 336169206 | 4,014 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 18,896 | 501,618 | SH | OTR | 501,618 | 0 | 0 | ||
FOREST ROAD ACQUISITION COR | UNIT 99/99/9999 | 34619V202 | 12,450 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
FORTRESS VALUE ACQUISI CORP | UNIT 03/31/2028 | 34964K207 | 17,325 | 1,750,000 | SH | OTR | 1,750,000 | 0 | 0 | ||
FORUM MERGER IV CORP | UNIT 03/15/2028 | 349875203 | 9,900 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 9,960 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
FTAC HERA ACQUISITION CORP | UNIT 02/28/2026 | G3728Y129 | 4,995 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
G SQUARED ASCEND I INC | UNIT 99/99/9999 | G4204R125 | 5,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 93,078 | 3,270,500 | SH | OTR | 3,270,500 | 0 | 0 | ||
GOL LINHAS AEREAS INTELIGENT | SPON ADR PFD NEW | 38045R206 | 657 | 85,838 | SH | OTR | 85,838 | 0 | 0 | ||
GORES HLDGS VIII INC | UNIT 02/01/2028 | 382863207 | 4,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
GORES HOLDINGS VII INC | UNIT 02/12/2028 | 38286T200 | 7,470 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
GORES METROPOULOS II INC | UNIT 01/31/2028 | 382873206 | 7,590 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
GORES TECHNOLOGY PARTNERS II | UNIT 03/16/2028 | 38287L206 | 5,982 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
GORES TECHNOLOGY PARTNERS IN | UNIT 03/16/2028 | 382870202 | 2,508 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 8,889 | 10,000,000 | PRN | OTR | 10,000,000 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 12,139 | 702,110 | SH | OTR | 1 | 702,110 | 0 | 0 | |
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 277,393 | 1,278,900 | SH | OTR | 1,278,900 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 5,230 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
HILTON WORLDWIDE HLDGS INC | COM | 43300A203 | 235,726 | 1,949,437 | SH | OTR | 1,949,437 | 0 | 0 | ||
HOWMET AEROSPACE INC | COM | 443201108 | 94,968 | 2,955,729 | SH | OTR | 2,955,729 | 0 | 0 | ||
HUDSON EXECUTIVE INVES III | UNIT 02/22/2026 | 44376L206 | 2,480 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
HUMANCO ACQUISITION CORP | COM CL A | 44487N109 | 4,069 | 408,900 | SH | OTR | 408,900 | 0 | 0 | ||
HUMANCO ACQUISITION CORP | *W EXP 99/99/999 | 44487N117 | 264 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 38,124 | 1,349,513 | SH | OTR | 1,349,513 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 6,075 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | 12,042 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
INNOVAGE HLDG CORP | COM | 45784A104 | 5,158 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
INPHI CORP | COM | 45772F107 | 311,290 | 1,744,800 | SH | OTR | 1,744,800 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 56,619 | 50,000,000 | PRN | OTR | 50,000,000 | 0 | 0 | ||
INTERPRIVATE II ACQUISITION | UNIT 99/99/9999 | 46064Q207 | 3,956 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
INTERPRIVATE III FINANCIAL P | UNIT 99/99/9999 | 46064R205 | 3,944 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
INTERPRIVATE IV INFRATECH PR | UNIT 03/05/2026 | 46064T201 | 5,934 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 28,347 | 630,500 | SH | OTR | 630,500 | 0 | 0 | ||
IOVANCE BIOTRAPEUTICS INC | COM | 462260100 | 150,385 | 4,750,000 | SH | OTR | 4,750,000 | 0 | 0 | ||
IQIYI INC | NOTE 3.750%12/0 | 46267XAB4 | 29,643 | 29,689,000 | PRN | OTR | 29,689,000 | 0 | 0 | ||
IQIYI INC | NOTE 2.000% 4/0 | 46267XAD0 | 75,715 | 81,762,000 | PRN | OTR | 81,762,000 | 0 | 0 | ||
IQIYI INC | NOTE 4.000%12/1 | 46267XAE8 | 20,685 | 20,000,000 | PRN | OTR | 20,000,000 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 785,922 | 4,069,181 | SH | OTR | 4,069,181 | 0 | 0 | ||
ISIS PHARMACEUTICALS INC DEL | NOTE 1.000%11/1 | 464337AJ3 | 24,797 | 24,435,000 | PRN | OTR | 24,435,000 | 0 | 0 | ||
JAWS MUSTANG ACQUISITION COR | UNIT 99/99/9999 | G50737116 | 8,120 | 800,000 | SH | OTR | 800,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 81,155 | 675,000 | SH | OTR | 675,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 25,538 | 25,000,000 | PRN | OTR | 25,000,000 | 0 | 0 | ||
KE HLDGS INC | SPONSORED ADS | 482497104 | 15,556 | 273,000 | SH | OTR | 273,000 | 0 | 0 | ||
KHOSLA VENTURES ACQUISITION | CL A | 482504107 | 6,060 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
KHOSLA VENTURES ACQUSTN CO I | COM CL A | 482505104 | 22,703 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
KHOSLA VENTURES ACQUT CO III | COM CL A | 482506102 | 28,062 | 2,809,000 | SH | OTR | 2,809,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 7,790 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
KKR ACQUISITION HOLDING I CO | UNIT 99/99/9999 | 48253T208 | 15,015 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 48,150 | 625,000 | SH | OTR | 625,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 11,308 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
LANDCADIA HOLDINGS IV INC | UNIT 05/01/2025 | 51477A203 | 4,950 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 48,083 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
LAZARD GROWTH ACQUISITION CO | UNIT 99/99/9999 | G54035129 | 3,000 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
LDH GROWTH CORP I | UNIT 03/17/2026 | G54094118 | 1,518 | 150,000 | SH | OTR | 150,000 | 0 | 0 | ||
LEVERE HOLDINGS CORP | UNIT 03/09/2026 | G5462L114 | 7,968 | 800,000 | SH | OTR | 800,000 | 0 | 0 | ||
LIVE OAK MOBILITY ACQUISI CO | UNIT 03/01/2028 | 538126202 | 2,495 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 13,276 | 810,500 | SH | OTR | 810,500 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | UNIT 99/99/9999 | 54319Q204 | 3,059 | 304,698 | SH | OTR | 304,698 | 0 | 0 | ||
LUFAX HOLDING LTD | ADS REP SHS CL A | 54975P102 | 142,781 | 9,833,399 | SH | OTR | 9,833,399 | 0 | 0 | ||
MASTERCARD INCORPORATED | CL A | 57636Q104 | 351,037 | 985,920 | SH | OTR | 985,920 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 451,794 | 1,916,248 | SH | OTR | 1,916,248 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 145,605 | 850,000 | SH | OTR | 850,000 | 0 | 0 | ||
MOMO INC | NOTE 1.250% 7/0 | 60879BAB3 | 96,829 | 110,077,000 | PRN | OTR | 110,077,000 | 0 | 0 | ||
NEW ORIENTAL ED & TECHNOLOGY | SPON ADR | 647581107 | 223,202 | 15,943,000 | SH | OTR | 15,943,000 | 0 | 0 | ||
NEW YORK TIMES CO | CL A | 650111107 | 120,456 | 2,379,622 | SH | OTR | 2,379,622 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 10,901 | 375,000 | SH | OTR | 375,000 | 0 | 0 | ||
NIGHTDRAGON ACQUISITION CORP | UNIT 02/26/20266 | 65413D204 | 4,080 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
NORTHERN GENESIS ACQUISITION | COMMON STOCK | 66516U101 | 2,758 | 278,026 | SH | OTR | 278,026 | 0 | 0 | ||
NORTHERN GENESIS ACQUISITION | *W EXP 01/15/202 | 66516U119 | 107 | 92,675 | SH | OTR | 92,675 | 0 | 0 | ||
NORTHERN STAR INVEST CORP II | UNIT 02/25/2028 | 66574L209 | 995 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
NORTHERN STAR INVEST CORP IV | UNIT 02/25/2028 | 66575B200 | 992 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 31,729 | 175,000 | SH | OTR | 175,000 | 0 | 0 | ||
NOVAVAX INC | NOTE 3.750% 2/0 | 670002AB0 | 16,100 | 10,000,000 | PRN | OTR | 10,000,000 | 0 | 0 | ||
NOVUS CAPITAL CORPORATION II | UNIT 99/99/9999 | 67012W203 | 7,000 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
NUANCE COMMUNICATIONS INC | DBCV 1.000%12/1 | 67020YAK6 | 12,942 | 7,000,000 | PRN | OTR | 7,000,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 26,125 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 23,344 | 3,215,434 | SH | OTR | 3,215,434 | 0 | 0 | ||
PATHFINDER ACQUISITION CORP | UNIT 02/17/2026 | G04119114 | 7,425 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
PG&E CORP | COM | 69331C108 | 85,390 | 7,292,042 | SH | OTR | 7,292,042 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 5,612 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
PLAYA HOTELS & RESORTS NV | SHS | N70544106 | 109,463 | 14,994,867 | SH | OTR | 14,994,867 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 30,058 | 764,262 | SH | OTR | 764,262 | 0 | 0 | ||
PLURALSIGHT INC | COM CL A | 72941B106 | 10,053 | 450,000 | SH | OTR | 450,000 | 0 | 0 | ||
PRIVETERRA ACQUISITION CORP | UNIT 99/99/9999 | 74275N201 | 1,491 | 150,000 | SH | OTR | 150,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 62,808 | 2,425,000 | SH | OTR | 2,425,000 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 123,596 | 2,538,423 | SH | OTR | 2,538,423 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 35,082 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 43,960 | 2,107,400 | SH | OTR | 2,107,400 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 6,435 | 6,783,000 | PRN | OTR | 6,783,000 | 0 | 0 | ||
RAYTHEON TECHNOLOGIES CORP | COM | 75513E101 | 369,537 | 4,782,411 | SH | OTR | 4,782,411 | 0 | 0 | ||
READY CAPITAL CORP | COM | 75574U101 | 16,778 | 1,250,226 | SH | OTR | 1,250,226 | 0 | 0 | ||
REALPAGE INC | COM | 75606N109 | 36,188 | 415,000 | SH | OTR | 415,000 | 0 | 0 | ||
REINVENT TECHNOLOGY PARTNERS | UNIT 03/12/2026 | G7484L114 | 7,530 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 7,688 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
REVOLUTION HEALTHCAR AQ CORP | UNIT 03/18/20266 | 76155Y207 | 20,100 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 73,854 | 1,609,730 | SH | OTR | 1,609,730 | 0 | 0 | ||
ROCKET INTERNET GRWT OPRT CO | UNIT 99/99/9999 | G7613T111 | 5,005 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
ROCKET INTERNET GRWT OPRT CO | UNIT 99/99/9999 | G7613T111 | 5,005 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 15,530 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
RXR ACQUISITION CORP | UNIT 01/01/2025 | 74981W206 | 5,910 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 25,823 | 345,000 | SH | OTR | 345,000 | 0 | 0 | ||
SALESFORCE COM INC | COM | 79466L302 | 302,312 | 1,426,875 | SH | OTR | 1,426,875 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 22,359 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 8,582 | 4,125,877 | SH | OTR | 4,125,877 | 0 | 0 | ||
SCION TECH GROWTH II | UNIT 99/99/9999 | G31070124 | 4,482 | 450,000 | SH | OTR | 450,000 | 0 | 0 | ||
SHERWIN WILLIAMS CO | COM | 824348106 | 291,618 | 395,141 | SH | OTR | 395,141 | 0 | 0 | ||
SIGNIFY HEALTH INC | CL A COM | 82671G100 | 2,926 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
SLAM CORP | UNIT 99/99/9999 | G8210L113 | 699 | 70,508 | SH | OTR | 70,508 | 0 | 0 | ||
SOARING EAGLE ACQUISITION CO | UNIT 02/23/2026 | G8354H100 | 5,060 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
SOCIAL LEVERAGE ACQUISN CORP | UNIT 99/99/9999 | 83363K201 | 7,463 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
SPARTAN ACQUISITION CORP III | UNIT 99/99/9999 | 84677R205 | 602 | 60,053 | SH | OTR | 60,053 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 885,798 | 2,235,000 | SH | Put | OTR | 2,235,000 | 0 | 0 | |
SUPERNOVA PARTN ACQ CO III L | UNIT 99/99/9999 | G8T90F110 | 7,000 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
SUPERNOVA PARTNERS ACQUISTN | UNIT 99/99/9999 | G8T86C113 | 2,008 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 7,800 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
SVF INVESTMENT CORP | CL A SHS | G8601L102 | 2,553 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
SVF INVESTMENT CORP | *W EXP 12/20/202 | G8601L128 | 104 | 50,000 | SH | OTR | 50,000 | 0 | 0 | ||
TAILWIND TWO ACQUISITION COR | UNIT 03/01/2028 | G86613117 | 9,880 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 24,100 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
THE MUSIC ACQUISITION CORP | UNIT 99/99/9999 | 62752R209 | 1,248 | 125,000 | SH | OTR | 125,000 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 88339KAA0 | 57,933 | 56,695,000 | PRN | OTR | 56,695,000 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 527,154 | 1,155,078 | SH | OTR | 1,155,078 | 0 | 0 | ||
THOMA BRAVO ADVANTAGE | COM CL A | G88272102 | 5,225 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
THUNDER BRIDGE CAP PRTNRS II | UNIT 02/15/2028 | 88605T209 | 7,418 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
TIGA ACQUISITION CORP | SHS CL A | G88672103 | 10,843 | 1,080,000 | SH | OTR | 1,080,000 | 0 | 0 | ||
TIGA ACQUISITION CORP | *W EXP 11/06/202 | G88672111 | 702 | 540,000 | SH | OTR | 540,000 | 0 | 0 | ||
T-MOBILE US INC | COM | 872590104 | 514,795 | 4,108,826 | SH | OTR | 4,108,826 | 0 | 0 | ||
TRANSUNION | COM | 89400J107 | 284,407 | 3,160,077 | SH | OTR | 3,160,077 | 0 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 47,295 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 10,107 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
UNUM THERAPEUTICS INC | COM | 19240Q201 | 5,268 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
VARIAN MED SYS INC | COM | 92220P105 | 26,480 | 150,000 | SH | OTR | 150,000 | 0 | 0 | ||
VECTOR ACQUISITION CORP II | CL A SHS | G9460A104 | 7,425 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
VIRGIN GROUP ACQUISIT CORP I | UNIT 99/99/9999 | G9460K110 | 9,930 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 277,118 | 1,308,829 | SH | OTR | 1,308,829 | 0 | 0 | ||
VPC IMPACT ACQU HOLDI III IN | UNIT 99/99/9999 | 91835J207 | 3,948 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
VPC IMPACT ACQUISITION HLDG | UNIT 03/05/2026 | G9460L100 | 1,972 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
WABTEC | COM | 929740108 | 391,600 | 4,946,946 | SH | OTR | 4,946,946 | 0 | 0 | ||
WARBURG PINCUS CAPTAL CORP I | UNIT 99/99/9999 | G9461D123 | 7,560 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
WARBURG PINCUS CAPTAL CORP I | UNIT 99/99/9999 | G9460M116 | 7,485 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
WILLIS TOWERS WATSON PLC LTD | SHS | G96629103 | 715,067 | 3,124,200 | SH | OTR | 1 | 3,124,200 | 0 | 0 | |
ZEALAND PHARMA A/S | SPONSORED ADR | 98920Y304 | 16,300 | 510,000 | SH | OTR | 510,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 43,920 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 18,948 | 600,000 | SH | OTR | 600,000 | 0 | 0 |